Cabot Corp Board Increases Share Repurchase Authorization by 10 Million Shares

$CBT
Major Chemicals
Industrials
Get the next $CBT alert in real time by email

Cabot Corporation (NYSE:CBT) Board of Directors authorized the Company to repurchase up to ten million additional shares of the Company's common stock, increasing the current amount of shares available for repurchase to approximately eleven million.

"Our ‘Creating for Tomorrow' strategy is underpinned by a balanced capital allocation framework of investing for advantaged growth and returning cash to shareholders through a combination of dividends and share repurchases. The Board's actions confirm our commitment to this strategy," said Sean Keohane, president and chief executive officer. "Returning cash to our shareholders is an important component of our capital allocation framework and this authorization demonstrates our confidence in the expected earnings performance and cash flow generation of our businesses over the coming years."

The timing and amount of any shares repurchased will be determined by Cabot's management based on its evaluation of market conditions and other factors. Shares will be repurchased in the open market or in privately negotiated transactions using the Company's existing sources of liquidity and free cash flow generated in the future. All shares repurchased will be retired and restored to the status of authorized but unissued shares of common stock of the Company. This authorization has no time limit and may be suspended or discontinued at any time.

About Cabot Corporation

Cabot Corporation (NYSE:CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company's website at cabotcorp.com. The Company regularly posts important information on its website and encourages investors and potential investors to consult the Cabot website regularly.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot's sources of cash to fund its repurchases, and Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.

Get the next $CBT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Q&A

New
  • What recent decision did Cabot Corporation's Board of Directors make regarding share repurchases?

    Cabot Corporation has authorized the repurchase of up to ten million additional shares, increasing the total available for repurchase to approximately eleven million shares.

  • How will Cabot determine the timing and amount of shares repurchased?

    The company plans to repurchase shares based on market conditions and other factors using existing liquidity and future cash flow.

  • What will happen to the shares that Cabot repurchases?

    The repurchased shares will be retired and returned to the status of authorized but unissued shares of common stock, with no time limit on the authorization.

  • What does the company's share repurchase authorization indicate about its capital allocation strategy?

    Cabot's capital allocation strategy focuses on investing for growth while also returning cash to shareholders through dividends and share repurchases, reflecting the company's confidence in future earnings and cash flow.

  • What type of statements regarding Cabot's business and repurchases are included in the press release?

    The press release contains forward-looking statements regarding cash sources for fund repurchases and business performance, highlighting inherent risks and uncertainties.

Recent Analyst Ratings for
$CBT

DatePrice TargetRatingAnalyst
11/11/2024$105.00Neutral → Underweight
JP Morgan
4/18/2024Buy → Hold
Deutsche Bank
3/27/2024$104.00Buy
Mizuho
1/8/2024$90.00 → $87.00Buy → Neutral
UBS
6/6/2023$87.00 → $80.00Overweight → Neutral
JP Morgan
3/13/2023$94.00Outperform
Credit Suisse
11/16/2022$80.00 → $90.00Hold → Buy
Deutsche Bank
1/4/2022$75.00 → $70.00Buy
UBS
More analyst ratings

$CBT
Press Releases

Fastest customizable press release news feed in the world

See more
  • Cabot Corporation to Announce Second Quarter 2025 Operating Results

    BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the second quarter of fiscal 2025 on Monday, May 5, 2025, after market close. The Company will host a conference call and live webcast to review the second quarter results beginning at 8:00 am (ET) on Tuesday, May 6, 2025. The call will be webcast by Notified and may be accessed at Cabot's website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at https://cabotog.gcs-web.com/. ABOUT CABOT CORPORATIONCabot Corporation (NYSE:CBT)

    $CBT
    Major Chemicals
    Industrials
  • Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025

    GREENWICH, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20, 2025.  The symposium will draw a variety of companies, with a focus on pricing power, margin recovery, interest rates, inventory stabilization, global trade policy, demand trends, and the M&A environment.  Attendees will also have the opportunity to meet with managements in a one-on-one setting. Agenda: 8:20amOpening RemarksRosemarie Morbelli, CFA Gabelli Funds  Wayne Pinsent, CFA Gabelli Funds   8:30Cabot Corporation (NYSE:CBT)*To Be Confirmed      9:00Arq, Inc. (NASDAQ:ARQ)Bob Rasmus, President

    $ARQ
    $AVD
    $CBT
    $CC
    Major Chemicals
    Industrials
    Agricultural Chemicals
    Investment Managers
  • Cabot Corp Reports First Quarter Fiscal 2025 Results

    BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its first quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.67 and Adjusted EPS of $1.76 which represents a 13% increase in Adjusted EPS compared to the same quarter in the prior yearReinforcement Materials segment EBIT of $130 million; up 1% compared to the same quarter in the prior yearPerformance Chemicals segment EBIT of $45 million; up 32% compared to the same quarter in the prior yearCash Flows from Operations of $124 million in the first fiscal quarter supported the return of $66 million of cash to shareholders in the quarter Hosted Investor Day highlighting growth

    $CBT
    Major Chemicals
    Industrials

$CBT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CBT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CBT
SEC Filings

See more

$CBT
Leadership Updates

Live Leadership Updates

See more
  • Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors

    Cabot Corporation (NYSE:CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a

    $CBT
    Major Chemicals
    Industrials
  • Cabot Corporation Commended by the International Carbon Black Association for Outstanding Safety Performance

    19 Carbon Black Facilities Across Global Network Receive Safety Awards Cabot Corporation (NYSE:CBT) today announced that 19 of its 20 carbon black manufacturing sites have been recognized by the International Carbon Black Association's (ICBA) Safety Performance Recognition Program. Across the company's global network, 18 of its carbon black facilities received the gold award, the highest recognition available, and one received the bronze award for their outstanding safety performance in 2023. For the industry overall, a total of 35 ICBA member manufacturing facilities were recognized for above average safety performance, with Cabot achieving over half of all awards granted as well as the

    $CBT
    Major Chemicals
    Industrials
  • Cabot Corporation Announces Changes to Board of Directors

    Cabot Corporation (NYSE:CBT) announced today that Michelle Williams, Ph.D., has been elected to its Board of Directors, effective September 13, 2023. She was also appointed a member of the Audit Committee of the Board of Directors, effective September 13, 2023. Prior to her retirement in 2021, Dr. Williams was Global Group President of Altuglas International, a manufacturer of polymethyl methacrylate (PMMA) and a subsidiary of Arkema S.A., a manufacturer of specialty chemicals and advanced materials. Dr. Williams has been a Director of Brady Corporation, a manufacturer and supplier of identification solutions and workplace safety products, since 2019, where she serves as Chair of the Techno

    $CBT
    Major Chemicals
    Industrials

$CBT
Financials

Live finance-specific insights

See more
  • Cabot Corporation to Announce Second Quarter 2025 Operating Results

    BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the second quarter of fiscal 2025 on Monday, May 5, 2025, after market close. The Company will host a conference call and live webcast to review the second quarter results beginning at 8:00 am (ET) on Tuesday, May 6, 2025. The call will be webcast by Notified and may be accessed at Cabot's website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at https://cabotog.gcs-web.com/. ABOUT CABOT CORPORATIONCabot Corporation (NYSE:CBT)

    $CBT
    Major Chemicals
    Industrials
  • Cabot Corp Reports First Quarter Fiscal 2025 Results

    BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its first quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.67 and Adjusted EPS of $1.76 which represents a 13% increase in Adjusted EPS compared to the same quarter in the prior yearReinforcement Materials segment EBIT of $130 million; up 1% compared to the same quarter in the prior yearPerformance Chemicals segment EBIT of $45 million; up 32% compared to the same quarter in the prior yearCash Flows from Operations of $124 million in the first fiscal quarter supported the return of $66 million of cash to shareholders in the quarter Hosted Investor Day highlighting growth

    $CBT
    Major Chemicals
    Industrials
  • Cabot Corporation Board Declares Dividend

    On Friday, January 10, 2025, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.43 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on March 14, 2025, to stockholders of record at the close of business on February 28, 2025. About Cabot Corporation Cabot Corporation (NYSE:CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For mor

    $CBT
    Major Chemicals
    Industrials

$CBT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more